64 related articles for article (PubMed ID: 22053557)
1. Low adiponectin serum level--reduced protective effect on the left ventricular wall thickness.
Selthofer-Relatić K; Radić R; Vcev A; Steiner R; Vizjak V; Sram M; Tripolski M; Kosović P; Bosnjak I; Selthofer R
Coll Antropol; 2011 Sep; 35(3):787-91. PubMed ID: 22053557
[TBL] [Abstract][Full Text] [Related]
2. Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females.
Selthofer-Relatić K; Radić R; Vizjak V; Vcev A; Kosović P; Bosnjak I; Selthofer R
Coll Antropol; 2008 Sep; 32(3):681-5. PubMed ID: 18982737
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
Kartal O; Inal V; Baysan O; Sağlam K
Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
[TBL] [Abstract][Full Text] [Related]
4. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin concentration and left ventricular hypertrophy in kidney transplant patients.
Adamczak M; Błach A; Kolonko A; Szotowska M; Chudek J; Franek E; Więcek A
Clin Transplant; 2011; 25(4):561-8. PubMed ID: 20964715
[TBL] [Abstract][Full Text] [Related]
6. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
[TBL] [Abstract][Full Text] [Related]
7. [Left ventricular hypertrophy in patient on dialysis].
Lovcić V; Sebetić D; Klobucić M; Kusec V
Acta Med Croatica; 2003; 57(1):61-4. PubMed ID: 12876866
[TBL] [Abstract][Full Text] [Related]
8. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
Cuspidi C; Giudici V; Negri F; Meani S; Sala C; Zanchetti A; Mancia G
J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
[TBL] [Abstract][Full Text] [Related]
10. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
Opadijo OG; Omotoso AB; Akande AA
Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus.
Komaba H; Igaki N; Goto S; Yokota K; Takemoto T; Hirosue Y; Goto T
Nephron Clin Pract; 2007; 107(3):c103-8. PubMed ID: 17890872
[TBL] [Abstract][Full Text] [Related]
12. Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension.
Siciliano M; Mettimano M; Dondolini-Poli A; Ballarin S; Migneco A; Annese R; Fazzari L; Fedeli P; Montebelli MR; Zuppi C; Savi L
Ital Heart J; 2000 Aug; 1(8):532-5. PubMed ID: 10994933
[TBL] [Abstract][Full Text] [Related]
13. Reverse correlation between ankle-brachial index and left ventricular hypertrophy in patients on maintenance haemodialysis.
Fu W; Ye C; Mei C; Rong S; Wang W
Nephrology (Carlton); 2006 Feb; 11(1):9-14. PubMed ID: 16509925
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy and heart failure in women.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
17. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
18. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
19. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
20. Association between left ventricular hypertrophy with retinopathy and renal dysfunction in patients with essential hypertension.
Shirafkan A; Motahari M; Mojerlou M; Rezghi Z; Behnampour N; Gholamrezanezhad A
Singapore Med J; 2009 Dec; 50(12):1177-83. PubMed ID: 20087555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
